Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study.

Foschi, D; Corsi, F; Lazzaroni, M; Sangaletti, O; Riva, P; La Tartara, G; Bevilacqua, M; Osio, M; Alciati, A; Bianchi Porro, G; Trabucchi, E

Foschi, D; Corsi, F; Lazzaroni, M; Sangaletti, O; Riva, P; La Tartara, G; Bevilacqua, M; Osio, M; Alciati, A; Bianchi Porro, G; Trabucchi, E.

Affiliation

Foschi D; I Unit of Surgery, Department of Clinical Sciences L Sacco, San Siro Clinical Institute, University of Milan, Milan, Italy. diego.foschi@unimi.it

Int J Obes (Lond) ; 31(4): 707-12, 2007 Apr.

Article in En | MEDLINE | ID: mdl-17006442

Subject(s)

Botulinum Toxins, Type A/administration & dosage; Neuromuscular Agents/administration & dosage; Obesity, Morbid/drug therapy; Adult; Body Mass Index; Body Size/physiology; Botulinum Toxins, Type A/adverse effects; Breath Tests/methods; Double-Blind Method; Female; Gastric Emptying/physiology; Gastric Fundus; Gastroscopy; Humans; Injections; Male; Middle Aged; Neuromuscular Agents/adverse effects; Obesity, Morbid/physiopathology; Pyloric Antrum; Satiety Response/physiology; Stomach/physiopathology; Treatment Outcome; Weight Loss/physiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Obesity, Morbid / Botulinum Toxins, Type A / Neuromuscular Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Int J Obes (Lond) Year: 2007 Document type: Article

Search on Google

XML

PubMed Links